Evaluation of the efficacy of the CRF1 antagonist GSK561679 in women with post-traumatic stress disorder (H-30433)
Are you a woman between the ages of 18-64 and suffer from PTSD? Baylor College of Medicine and the Michael E. DeBakey VA Medical Center are conducting a study to test the safety and effectiveness of an experimental drug for PTSD, GSK561679, compared to a placebo. The total duration of the study will be about 12 weeks. The study is sponsored by the National Institutes of Health, and is being conducted at three sites nationwide. Participation may be compensated. For more information, please contact our research coordinator at (877) 96-BCM-MOOD or firstname.lastname@example.org. All inquiries are confidential.